Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ovid Therapeutics Inc. | Director | Stock Option (Right to Buy) | 30K | Feb 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OVID | Ovid Therapeutics Inc. | Feb 22, 2024 | 1 | $0 | 4 | Feb 26, 2024 | Director |
OVID | Ovid Therapeutics Inc. | Feb 23, 2023 | 1 | $0 | 4 | Feb 27, 2023 | Director |
OVID | Ovid Therapeutics Inc. | Apr 8, 2022 | 1 | $0 | 4 | Apr 12, 2022 | Director |
OVID | Ovid Therapeutics Inc. | Feb 3, 2022 | 1 | $0 | 4 | Feb 4, 2022 | Director |
OVID | Ovid Therapeutics Inc. | Jun 11, 2021 | 1 | $0 | 4 | Jun 11, 2021 | Director |
OVID | Ovid Therapeutics Inc. | May 17, 2021 | 1 | $0 | 4 | May 18, 2021 | Director |